Noxopharm Limited 2026 Extraordinary General Meeting Physical Meeting Noxopharm Limited (ASX:NOX) advises that it will hold an Extraordinary General Meeting as a physical meeting, in a manner that is consistent with its Constitution and the Corporations Act 2001. Meeting date The Extraordinary...
Notice of Extraordinary General Meeting/Proxy Form
Filed with ASX · · 43 pages · English
Summary by 6ix AI
The meeting will address several resolutions, including the conversion of convertible notes and the ratification of placement shares. Shareholders are encouraged to participate either in person or by proxy, with specific instructions provided for proxy voting. The notice emphasizes the importance of shareholder votes on the proposed resolutions affecting their shareholding.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from Noxopharm
- Results of Meeting
- Noxopharm 2026 AGM Corporate Presentation
- Noxopharm 2026 AGM Chair's Address
- Noxopharm receives $1.4 million R&D tax incentive rebate
- Noxopharm Investor Webinar
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm